Lupin launches generic Meloxicam capsules

Lupin launches generic Meloxicam capsules

56
Medicine
Picture: Pixabay

Last Updated on December 30, 2020 by The Health Master

Lupin Limited, global pharmaceutical company, announced the launch of the United States Food and Drug Administration (USFDA) approved meloxicam capsules, 5 mg, and 10 mg.

Meloxicam capsules, 5 mg and 10 mg, is the generic equivalent of Vivlodex capsules, 5 mg and 10 mg, of Zyla Life Sciences US, Inc., and indicated for management of osteoarthritis (OA) pain.

Meloxicam capsules had an annual sales of approximately US$ 11 million in the US, according to IQVIA MAT October 2020.


The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram..

Follow and connect with us on Facebook and Linkedin

Go to main website, click here